The Medicines Company (NASDAQ: MDCO) announced today that it has received European approval for the use of Angiox (bivalirudin) as ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE